Followers | 71 |
Posts | 3647 |
Boards Moderated | 1 |
Alias Born | 09/16/2009 |
Wednesday, October 11, 2017 3:23:42 PM
With that said...
VDRM is a stock play and in fact the company will eventually get the product out the door. When that happens we all know the share price will raise on high volume as it has done before.
As for the lawsuit brought on by Keough, I have spent the money and time reading ALL of the documents submitted to the court to date. MY OPINION on the content is that the suit will be dismissed and Keough will have to pay for the court cost. If you read the documents I believe you would come up with the same conclusion.
Last but not least, CEO Otiko should loosen up on the time frames he sets for the challenges the company has ahead of it's self. It's no different than asking a contractor when a project will be finished, they are never on time. Too many unpredictable problems arise before the task is complete.
I have a very large investment in this company because I have faith in the product and the management to deliver the product to the public. When it does happen there will be lives and limbs saved by Vitastem healing diabetic ulcers around the world and shareholders will be rewarded for their faith in the mission.
So are you in VDRM or you just here to beat it up?
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM